Leuk Res
Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore 560029, India.
Published: June 2008
Objective: We report probably the first case of bilateral irreversible sensorineural hearing loss caused by Imatinib.
Method: A review of the world literature, concerning Imatinib toxicity is presented.
Results: We report a case of bilateral irreversible sensorineural hearing loss, in a 19-year-old male patient of chronic myeloid leukemia after 3 months of Imatinib therapy. Audiometric evaluation documented the findings.
Conclusion: To the best of our knowledge, this is the first case report of Imatinib induced sensorineural hearing loss. This case indicates that treating oncologists should keep in mind that this drug too can produce ototoxicity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.leukres.2007.11.039 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.